Merck Recalls 1.2M Vaccine Doses

Law360, New York (December 14, 2007, 12:00 AM EST) -- Merck & Co. is recalling 11 lots of its Haemophilus influenzae type B vaccine Pedvaxhib and two lots of Comvax, a Haemophilus influenzae type B/hepatitis B vaccine, saying that it can't guarantee the sterility of those specific lots. Meanwhile, Canada's national health agency is advising against using three lots of Merck Frosst Canada's MMR-II vaccine.

Health Canada -- Canada's federal health department -- is advising against using three lots of measles, mumps and rubella vaccine distributed by Merck unit Merck Frosst Canada, while five suspected cases...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.